| Kristine E Flowers, MD | |
|
110 E 5th Ave, Antigo, WI 54409-2710 | |
| (715) 623-2351 | |
| Not Available |
| Full Name | Kristine E Flowers |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 30 Years |
| Location | 110 E 5th Ave, Antigo, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669405676 | NPI | - | NPPES |
| 32382900 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 38963 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aspirus At Home | Calumet, MI | Home health agency |
| Regional Hospice Services | Ashland, WI | Hospice |
| Aspirus Iron River Hospital & Clinics, Inc | Iron river, MI | Hospital |
| Dickinson County Memorial Hospital | Iron mountain, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aspirus Iron River Hospital And Clinics Inc | 5294648929 | 25 |
| Aspirus Ironwood Hospital And Clinics Inc | 9032013198 | 67 |
News Archive
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that shipping of the 2010-2011 formulation of its seasonal influenza vaccine Fluzone Influenza Virus Vaccine is underway in the U.S.
Biomerica, Inc. today reported net sales of $1,099,880 for the three months ended November 30, 2009, compared to $1,120,575 for the same period in the previous year. Net sales were $2,248,401 for the first six months of fiscal 2010 compared to $2,314,920 for the first six months in fiscal 2009.
The drugs include traditional non-steroidal anti-inflammatory drugs as well as new generation anti-inflammatory drugs, known as COX-2 inhibitors. The researchers say that doctors and patients need to be aware that prescription of any anti-inflammatory drug needs to take cardiovascular risk into account.
A study led by The University of Texas MD Anderson Cancer Center showed that treatment combining lower doses of chemotherapy with the monoclonal antibody inotuzumab ozogamicin (INO), with or without the drug blinatumomab, is safe and effective in patients over 60 years of age who were newly diagnosed with a high-risk form of acute lymphoblastic leukemia (ALL) known as Philadelphia chromosome-negative ALL.
› Verified 6 days ago
| Entity Name | Aspirus Iron River Hospital & Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497750830 PECOS PAC ID: 5294648929 Enrollment ID: O20031110000264 |
News Archive
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that shipping of the 2010-2011 formulation of its seasonal influenza vaccine Fluzone Influenza Virus Vaccine is underway in the U.S.
Biomerica, Inc. today reported net sales of $1,099,880 for the three months ended November 30, 2009, compared to $1,120,575 for the same period in the previous year. Net sales were $2,248,401 for the first six months of fiscal 2010 compared to $2,314,920 for the first six months in fiscal 2009.
The drugs include traditional non-steroidal anti-inflammatory drugs as well as new generation anti-inflammatory drugs, known as COX-2 inhibitors. The researchers say that doctors and patients need to be aware that prescription of any anti-inflammatory drug needs to take cardiovascular risk into account.
A study led by The University of Texas MD Anderson Cancer Center showed that treatment combining lower doses of chemotherapy with the monoclonal antibody inotuzumab ozogamicin (INO), with or without the drug blinatumomab, is safe and effective in patients over 60 years of age who were newly diagnosed with a high-risk form of acute lymphoblastic leukemia (ALL) known as Philadelphia chromosome-negative ALL.
› Verified 6 days ago
| Entity Name | Aspirus Ironwood Hospital & Clinics Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992704753 PECOS PAC ID: 9032013198 Enrollment ID: O20031121000096 |
News Archive
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that shipping of the 2010-2011 formulation of its seasonal influenza vaccine Fluzone Influenza Virus Vaccine is underway in the U.S.
Biomerica, Inc. today reported net sales of $1,099,880 for the three months ended November 30, 2009, compared to $1,120,575 for the same period in the previous year. Net sales were $2,248,401 for the first six months of fiscal 2010 compared to $2,314,920 for the first six months in fiscal 2009.
The drugs include traditional non-steroidal anti-inflammatory drugs as well as new generation anti-inflammatory drugs, known as COX-2 inhibitors. The researchers say that doctors and patients need to be aware that prescription of any anti-inflammatory drug needs to take cardiovascular risk into account.
A study led by The University of Texas MD Anderson Cancer Center showed that treatment combining lower doses of chemotherapy with the monoclonal antibody inotuzumab ozogamicin (INO), with or without the drug blinatumomab, is safe and effective in patients over 60 years of age who were newly diagnosed with a high-risk form of acute lymphoblastic leukemia (ALL) known as Philadelphia chromosome-negative ALL.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristine E Flowers, MD 3000 Westhill Dr, Suite 303, Wausau, WI 54401-3795 Ph: () - | Kristine E Flowers, MD 110 E 5th Ave, Antigo, WI 54409-2710 Ph: (715) 623-2351 |
News Archive
Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that shipping of the 2010-2011 formulation of its seasonal influenza vaccine Fluzone Influenza Virus Vaccine is underway in the U.S.
Biomerica, Inc. today reported net sales of $1,099,880 for the three months ended November 30, 2009, compared to $1,120,575 for the same period in the previous year. Net sales were $2,248,401 for the first six months of fiscal 2010 compared to $2,314,920 for the first six months in fiscal 2009.
The drugs include traditional non-steroidal anti-inflammatory drugs as well as new generation anti-inflammatory drugs, known as COX-2 inhibitors. The researchers say that doctors and patients need to be aware that prescription of any anti-inflammatory drug needs to take cardiovascular risk into account.
A study led by The University of Texas MD Anderson Cancer Center showed that treatment combining lower doses of chemotherapy with the monoclonal antibody inotuzumab ozogamicin (INO), with or without the drug blinatumomab, is safe and effective in patients over 60 years of age who were newly diagnosed with a high-risk form of acute lymphoblastic leukemia (ALL) known as Philadelphia chromosome-negative ALL.
› Verified 6 days ago
Theodore C Fox, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 110 E 5th Ave, Antigo, WI 54409 Phone: 715-623-2351 | |
Kyle Dembowiak, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 112 E 5th Ave, Antigo, WI 54409 Phone: 715-623-2331 | |
Bartley R Kneeland, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 110 E 5th Ave, Antigo, WI 54409 Phone: 715-623-2351 | |
Charles A Heuss, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: N2166 Maple Rd, Antigo, WI 54409 Phone: 715-623-5803 | |
Gary M Hegranes, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 110 E 5th Ave, Antigo, WI 54409 Phone: 715-623-2351 | |
Steve A Weber, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1111 Langlade Road, Antigo, WI 54409 Phone: 715-623-3761 Fax: 715-623-3764 |